In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells

In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells

Acute myelogenous leukemia (AML) blast cells show high-affinity degradation of low-density lipoprotein (LDL), suggesting an increased expression of cellular LDL receptors. LDE is a lipid microemulsion easily synthesized in vitro which is known to mimic the metabolic pathway of LDL. We used LDE as a...

Full description

Bibliographic Details
Main Authors:	P.E. Dorlhiac-Llacer, M.V. Marquezini, O. Toffoletto, R.C.G. Carneiro, R.C. Maranhão, D.A.F. Chamone
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2001-10-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	cytotoxicity acute myelogenous leukemia daunorubicin low-density lipoprotein LDE complex RT-PCR
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001000004

Similar Items

Transferência simultânea de lipídeos de um modelo artificial de lipoproteína (LDE) para a lipoproteína de alta densidade (HDL)
by: Ana Cristina Lo Prete
Published: (2007)

Transferência simultânea de lipídeos de um modelo artificial de lipoproteína (LDE) para a lipoproteína de alta densidade (HDL)
by: Prete, Ana Cristina Lo
Published: (2007)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
by: Daniel Cacic, et al.
Published: (2021-04-01)

Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose
by: Adriana Bulgarelli
Published: (2010)

Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose
by: Bulgarelli, Adriana
Published: (2010)

Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
by: Amedeo Lonardo
Published: (2021-01-01)

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
by: Punniyakoti T. Veeravedu, et al.
Published: (2011-03-01)

Potential effects of pomegranate on lipid peroxidation and pro-inflammatory changes in daunorubicin-induced cardiotoxicity in rats
by: Hayder M Al-Kuraishy, et al.
Published: (2016-01-01)

Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment
by: Hussain Mubarak Al-Aamri, et al.
Published: (2021-04-01)

Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin
by: Kumar Atul, et al.
Published: (1994-01-01)

Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia
by: Indu M Nair, et al.
Published: (2016-01-01)

Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells
by: Michela Codini, et al.
Published: (2018-11-01)

A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits
by: Anna Potáčová, et al.
Published: (2007-01-01)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
by: Lalit S Raut
Published: (2015-01-01)

Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma: the DD Protocol
by: Frederico Luiz Dulley, et al.

Quercetin as a Potential Modulator of P-Glycoprotein Expression and Function in Cells of Human Pancreatic Carcinoma Line Resistant to Daunorubicin
by: Piotr Dziegiel, et al.
Published: (2010-02-01)

Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity
by: Yang Liu, et al.
Published: (2015-12-01)

Acute appendicitis revealing a diagnosis of chronic myelogenous leukemia
by: Rita Ahmad, et al.
Published: (2021-04-01)

Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia
by: Leo Reap, DO, et al.
Published: (2020-01-01)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
by: Bao W, et al.
Published: (2019-04-01)

Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella
by: Feio DC, et al.
Published: (2017-05-01)

Daunorubicin induced Stevens‐Johnson syndrome: A case report
by: Preeti Shakya, et al.
Published: (2021-07-01)

Different influence of Arac combined with idarubicin and with daunorubicin on malignant molecule expression of acute myelocytic leukemia
by: Abudourexiti Nuerbiya, et al.
Published: (2018-05-01)

ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines
by: Hassan Dariushnejad, et al.
Published: (2014-03-01)

Acute Myelogenous Leukemia Mimicking Fulminant Periorbital Cellulitis
by: Abbas Bagheri, et al.
Published: (2013-01-01)

Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
by: Tássia S. Tavares, et al.
Published: (2020-10-01)

Development, Characterization and Application of a Reactive Bulking Agent for Wall Control
by: Silva, Guillermo C.O.
Published: (2007)

Troponin-I and left ventricular function in pediatric high-risk acute lymphoblastic leukemia after daunorubicin treatment
by: Rinche Annur, et al.
Published: (2021-03-01)

The first attempt on fabrication of a nano-biosensing platform and exploiting first-order advantage from impedimetric data: Application to simultaneous biosensing of doxorubicin, daunorubicin and idarubicin
by: Shokoufeh Soleimani, et al.
Published: (2020-08-01)

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia
by: Fu-rong Liu, et al.
Published: (2017-01-01)

Acute myelogenous leukemia revealed by acute appendicitis
by: Sanae El Marzguioui, et al.
Published: (2020-01-01)

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01)

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
by: Mateja Grat, et al.
Published: (2004-12-01)

Effect of daunorubicin drug with and without cimetidine on the nucleated cells of bone marrow of balb/c mouse
by: ali asghar Kiani, et al.
Published: (2004-01-01)

Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy
by: Mouli Chakraborty, et al.
Published: (2018-04-01)

Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 Cells
by: Daniel Cacic, et al.
Published: (2021-07-01)

Estudos fotofísicos e fotobiológicos de sistemas de liberação contendo o fármaco fotossensível cloro-ftalocianina de alumínio para aplicação em terapia fotodinâmica
by: Emanoel Pedro de Oliveira Silva
Published: (2016)

Cinética plasmática e captação da associação de uma microemulsão rica em colesterol ao quimioterápico oleato de etoposideo em pacientes com câncer de ovário
by: Carolina Heitmann Mares Azevedo
Published: (2004)

Estudos fotofísicos e fotobiológicos de sistemas de liberação contendo o fármaco fotossensível cloro-ftalocianina de alumínio para aplicação em terapia fotodinâmica
by: Silva, Emanoel Pedro de Oliveira
Published: (2016)

Cinética plasmática e captação da associação de uma microemulsão rica em colesterol ao quimioterápico oleato de etoposideo em pacientes com câncer de ovário
by: Azevedo, Carolina Heitmann Mares
Published: (2004)